Treating DNA Repair-deficient Breast Cancers
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
Later this week, more than 200 researchers will convene in Montreal for a four-day conference on DNA Repair: Tumor...